Processo di ricerca

477 figure da ricerca revisionata da esperti

Tutti Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum

All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other

Figure 2 Chart

Statistical analysis from research investigating computational prediction of new therapeutic effects of probiotics, comparing treatment groups and control conditions.

Computational prediction of new therapeutic effects of probiotics.

Figure 3 Chart

Measured parameters from a study evaluating computational prediction of new therapeutic effects of probiotics, contributing to the overall assessment of probiotics are living microorganisms that provide health benefits to their hosts, potentially aiding in the treatment.

Computational prediction of new therapeutic effects of probiotics.

Figure 4 Chart

Graphical representation of outcomes in a study of computational prediction of new therapeutic effects of probiotics, highlighting trends observed across experimental conditions.

Computational prediction of new therapeutic effects of probiotics.

Figure 5 Chart

Quantitative data from a study on computational prediction of new therapeutic effects of probiotics, presenting measured outcomes relevant to the investigation of probiotics are living microorganisms that provide health benefits to their hosts, potentially aiding in the treatment.

Computational prediction of new therapeutic effects of probiotics.

Figure 1 Chart

Experimental results examining gut microbiota, with data points illustrating key findings related to this study explored the effect of plant-derived indigo supplementation on intestinal inflammation using in vivo, in v.

Gut microbiota-derived butyrate mediates the anticolitic effect of indigo supplementation through regulating …

Figure 2 Chart

Statistical analysis from research investigating gut microbiota, comparing treatment groups and control conditions.

Gut microbiota-derived butyrate mediates the anticolitic effect of indigo supplementation through regulating …

Figure 2

Fig 1. Study participant selection and follow-up. https://doi.org/10.1371/journal.pone.0269561.g001

Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.

Figure 3

Fig 2. Comparison of fecal microbiota in congenital chloride diarrhea (CLD), CLD-associated inflammatory bowel disease (CLD IBD), Crohn’s disease (CD), and healthy controls. Shown are Principal-coordinate Analysis (PcoA) plots based …

Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.

Figure 4

Fig 3. Microbiota composition in congenital chloride diarrhea (CLD), CLD-associated IBD (CLD IBD), Crohn’s disease (CD), and healthy controls. Shown are family-level microbiota composition for the taxa with significant differences …

Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.

Figure 5

Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.

Figure 6 Chart

Experimental results examining effect of Nuts on Gastrointestinal Health, with data points illustrating key findings related to nuts are high nutrient-dense foods containing healthy lipids, dietary fiber, and bioactive phytochemicals, including .

Effect of Nuts on Gastrointestinal Health.

Figure 1. The ﬂowchart of study protocol.

Figure 6 Chart

Supplementary outcome data from the randomized trial evaluating single-strain probiotics for irritable bowel syndrome, comparing gastrointestinal symptom improvements across treatment arms.

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or …

Figure 2. The effect of probiotic intervention on clinical improvement assessed by IBS-SSS scores (a–f). * indicates a statistically signiﬁcant improvement (p < 0.05) between both the groups given probiotic intervention and the placebo group in the tot

Figure 7 Chart

Probiotic intervention outcomes assessed by IBS Severity Scoring System (IBS-SSS) in a three-arm clinical trial. Both Bifidobacterium lactis BI040 and Bacillus coagulans BC300 groups showed statistically significant improvement in total IBS-SSS scores compared to placebo.

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or …

Figure 8 Chart

Supplementary outcome data from the randomized trial evaluating single-strain probiotics for irritable bowel syndrome, comparing gastrointestinal symptom improvements across treatment arms.

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or …

Figure 9 Chart

Supplementary outcome data from the randomized trial evaluating single-strain probiotics for irritable bowel syndrome, comparing gastrointestinal symptom improvements across treatment arms.

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or …

Figure 6 Chart

Extended analysis of bovine colostrum's effects on inflammatory cytokine profiles in the Caco-2/THP-1 co-culture system, demonstrating dose-dependent immunomodulatory activity.